Your search has returned 63 results
recall
Alert: Westminster Pharmaceuticals Irbesartan Tablets, USP 75 Mg, 150 Mg, and 300 Mg
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP (Expanded recall)
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Torrent Pharmaceuticals Losartan Potassium Tablets, USP and Losartan Potassium /Hydrochlorothiazide Tablets, USP (Expanded Recall)
Presence of N-Methylnitrosobutyric acid
recall
Alert: Stokes Healthcare Pilocarpine 0.1% Ophthalmic Solution
Presence of high level of preservative benzalkonium chloride
recall
Alert: Sodium Chloride Injection, USP, 0.9%
Product labeling incorrectly stating stoppers do not contain Latex (The stoppers contain natural rubber latex.)
recall
Alert: Smiths Medical sterile saline and sterile water products for inhalation
Potential exposure to infectious agents (bacillus infantis and staphylococcus epidermidis)
recall
Alert: RXQ Compounding recalls all sterile human and animal products due to lack of sterility process assurance
Lack of sterility process assurance
recall
Alert: Robaxin methocarbamol tablets, USP
Incorrect daily dosing information on the label due to labeling error
recall
Alert: Premier Pharmacy Labs recalls all sterile products due to lack of sterility assurance
Lack of sterility assurance
recall
Alert: Plastikon Healthcare recalls Major Pharmaceuticals Milk of Magnesia 2400 mg/30 mL Oral Suspension
Possible microbial contamination
recall
Alert: Norbrook Laboratories Noromectin Injection (ivermectin)
Product sterility cannot be assured.
recall
Alert: Norbrook Laboratories Ivermax 1% Injection (ivermectin)
Product sterility cannot be assured.
recall
Alert: Norbrook Laboratories Enroflox 100 Injection (enrofloxacin)
Product sterility cannot be assured.
recall
Alert: Mylan nizatidine capsules
Mylan Pharmaceuticals recalls nizatidine capsules due to potential NDMA (Nitrosodimethylamine) impurity.
recall
Alert: Macleods Pharmaceuticals Losartan Potassium/Hydrochlorothiazide Combination Tablets 100mg/25mg
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Macleod's Pharmaceuticals recalls Losartan Potassium and Losartan Potassium/Hydrochlorothiazide Combination tablets
Presence of NMBA (N-Nitroso-N
recall
Alert: Losartan Potassium Tablets, USP (Expanded Recall)
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP (Expanded Recall)
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Losartan Potassium Tablets, USP and Losartan Potassium / Hydrochlorothiazide Tablets, USP – Expanded
Detection of trace amounts of N-Methylnitrosobutyric acid (NMBA)
recall
Alert: Losartan Potassium Tablets USP 50mg - Expanded
Trace amounts of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA)
recall
Alert: Losartan Potassium Tablets USP 50mg & 100mg - Expanded
Presence of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)
